What to do if your pet dog receives a devastating diagnosis of cancer? One option is to enroll the pet in an NCI-supported clinical trial testing a new cancer treatment. Pet animals will receive treatment under the care of board-certified veterinary oncologists who share our goal of alleviating the suffering of companion animals with cancer
Comparative Oncology Program
Dedicated to improving cancer treatment through novel human tissue models and new treatment paradigms.
Comparative Oncology Program
About
Comparative oncology is the study of naturally developing cancers in animals as models for human disease. Spontaneous cancers in dogs and cats are an underused group of naturally occurring malignancies that share many features with human cancers such as osteosarcoma, prostate and breast cancers, non-Hodgkin's lymphoma, melanoma, soft tissue sarcoma, head and neck carcinoma, and virally induced lymphomas (see Disease Information).
For more information about Comparative Oncology, click here.
Research
The COP complements translational research efforts through the characterization and use of relevant and naturally occurring cancer models that develop in pet animals.
Trial Sponsors
The Comparative Oncology Trials Consortium (COTC) is an active network of 20 academic comparative oncology centers, centrally managed by the Comparative Oncology Program, that functions to design and execute clinical trials in dogs with cancer to assess novel therapies.
Latest Tweets
@NCICompOncMeet Benny! Benny is one of the dogs enrolled on our OSA study. Even after his amputation, he still loves to swim in the pool at the local dog park, wrestle w/ his sibling cat, and his baby brother (5 mo. old Rottweiler puppy). Benny is living life to the fullest! @Morris_Animal https://t.co/N1UEPYHp55
- @NCICompOnc
Dr. LeBlanc presented at the Frontiers in Pediatric Cancer Research, Prevention, and Therapy meeting at the Huntsman Cancer Institute in Salt Lake City, UT. https://t.co/PNmSplh54L https://t.co/a3QI3ssJdO
- @NCICompOnc
Every dog that enrolled on our osteosarcoma study. A big thank you to all the dogs and owners! https://t.co/vqAE1wvuhO
- @NCICompOnc
Dr. LeBlanc presenting at the FDA-AACR workshop #OCEIONonClinModels https://t.co/o0FNovWBCo
